Biolegend, 345012, APC anti-human CD366 (Tim-3) Antibody, 100tests

CD366 (Tim-3) is a transmembrane protein also known as T cell immunoglobulin and mucin domain containing protein-3. Tim-3 is expressed at high levels on activated T cells (preferentially on Th1 cells, monocytes/macrophages, and dendritic cells). Tim-3 has also been shown to exist as a soluble protein. Cells expressing Tim-3 are present at high levels in the CNS of animals at the onset of experimental autoimmune encephalomyelitis (EAE), a disease mediated by lymphocytes secreting Th1-like cytokines. Tim-3 has been proposed to inhibit Th1-mediated immune responses and promote immunological tolerance.
100tests
Verified Reactivity: Human
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: Human Tim-3 fusion protein
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Red Laser (633 nm)
Application Notes: Additional reported applications (for relevant formats of this clone) include: costimulation1 (clone 2E2 has been shown to enhance T-cell receptor mediated activation and cytokine secretion) and blocking2,3.
Application References(PubMed link indicates BioLegend citation): Hastings WD, et al. 2009. Eur. J. Immunol. 39:2492. (Costim) Jones RB, et al. 2008. J. Exp. Med. 205:2763. (Block) Klibi J, et al 2009. Blood 113:1957. (FC, Block)
Product Citations: Iwahori K, et al. 2019. Sci Rep. 2.205555556. PubMed Cheng K, et al. 2023. Int J Mol Sci. 24:. PubMed Xiao Q, et al. 2023. Bio Protoc. 13:e4655. PubMed Campisi L, et al. 2022. Nature. 606:945. PubMed Khuisangeam N, et al. 2022. J Immunol Res. 2022:2449373. PubMed Sharma AL, et al. 2022. iScience. 25:105651. PubMed Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed Chen M, et al. 2021. Cancers (Basel). 13:. PubMed Halim L, et al. 2022. Front Immunol. 13:836549. PubMed Zhou Y, et al. 2017. Front Cell Infect Microbiol. 7:457. PubMed Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed Kwon M, et al. 2020. Clin Cancer Res. 1644:26. PubMed Zhang D, et al. 2020. Oncoimmunology. 9:1744921. PubMed Lucas C, et al. 2021. Nature. Online ahead of print. PubMed Lam AJ, et al. 2021. Cell Reports. 36(5):109494. PubMed Li G, et al. 2021. Front Immunol. 12:800928. PubMed Zou F, et al. 2021. Mol Ther. 29:1794. PubMed Picard E, et al. 2019. Oncoimmunology. 8:e1527498. PubMed Zhang J, et al. 2022. Nature. 609:369. PubMed Alishah K, et al. 2021. J Transl Med. 19:482. PubMed Kotetsu Y, et al. 2021. Biomedicines. 9:. PubMed Li P, et al. 2022. Front Oncol. 12:917400. PubMed RY H, et al. 2016. Oncoimmunology. 6:e1249561. PubMed Li N, et al. 2020. Oncoimmunology. 9:1824643. PubMed Saraiva DP, et al. 2018. Front Immunol. 2.184027778. PubMed Wei J, et al. 2019. J Immunother Cancer. 7:209. PubMed Saygin C, et al. 2021. Leukemia. 35:3406. PubMed Stempin CC, et al. 2021. Cancers (Basel). 13:. PubMed McGowan J, et al. 2019. Front Immunol. 10:1553. PubMed
RRID: AB_2561717 (BioLegend Cat. No. 345011) AB_2561718 (BioLegend Cat. No. 345012)
Structure: Transmembrane protein containing immunoglobulin domain and mucin-like domain; can exist as a soluble form lacking mucin and transmembrane domains
Distribution: Activated T cells, preferentially on Th1 cells, monocytes, dendritic cells
Function: Plays a role in regulating macrophage activation, T cell apoptosis and immune tolerance
Ligand/Receptor: Galectin-9
Cell Type: Dendritic cells, Monocytes, T cells, Th1, Tregs
Biology Area: Immunology, Inhibitory Molecules
Molecular Family: CD Molecules, Immune Checkpoint Receptors
Antigen References: 1. Hafler DA and Kuchroo V. 2008. J. Exp. Med. 205:2699. 2. Zhu C, et al. 2005. Nat. Immunol. 6:1245. 3. Wang F, et al. 2009. Immunobiology 214:342.
Gene ID: 84868
UniProt: View information about CD366 on UniProt.org
Clone: F38-2E2
Regulatory Status: RUO
Workshop: HCDM listed
Other Names: T cell immunoglobulin and mucin domain containing protein 3, hepatitis virus cellular receptor 2, CD366
Isotype: Mouse IgG1, κ